Stock ITOS ITEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
17.44 USD +43.07% Intraday chart for iTeos Therapeutics, Inc. +49.57% +59.27%
May. 10 Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating MT
May. 10 ITeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ITEOS THERAPEUTICS, INC. Stock iTeos Therapeutics, Inc.
 627M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. ITOS Stock
  4. Charts iTeos Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW